165 related articles for article (PubMed ID: 28887108)
1. Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells.
Kawakami T; Okano T; Takeuchi S; Osumi K; Soma Y; Itoh M; Hirobe T; Jimbow K
J Invest Dermatol; 2018 Jan; 138(1):150-158. PubMed ID: 28887108
[TBL] [Abstract][Full Text] [Related]
2. Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells.
Gledhill K; Guo Z; Umegaki-Arao N; Higgins CA; Itoh M; Christiano AM
PLoS One; 2015; 10(8):e0136713. PubMed ID: 26308443
[TBL] [Abstract][Full Text] [Related]
3. Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells.
Sułkowski M; Kot M; Badyra B; Paluszkiewicz A; Płonka PM; Sarna M; Michalczyk-Wetula D; Zucca FA; Zecca L; Majka M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884599
[TBL] [Abstract][Full Text] [Related]
4. Melanocyte Differentiation From Induced Pluripotent Stem Cells Derived From Human Adipose-Derived Stem Cells.
Huang WS; Wei LG; Li JK; Fu KY; Huang TC; Hsieh PS; Huang NC; Dai LG; Chang FW; Loh SH; Chen YH; Yang BH; Shiau CY; Wu GJ; Dai NT
Ann Plast Surg; 2019 Jan; 82(1S Suppl 1):S119-S125. PubMed ID: 30516561
[TBL] [Abstract][Full Text] [Related]
5. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
[TBL] [Abstract][Full Text] [Related]
6. [Melanocytes derived from pluripotent stem cells: a new biological resource for pigmentary disorders].
Nissan X; Lemaitre G; Peschanski M; Baldeschi C
Med Sci (Paris); 2011 Nov; 27(11):935-8. PubMed ID: 22130018
[No Abstract] [Full Text] [Related]
7. Improved method of differentiation, selection and amplification of human melanocytes from the hair follicle cell pool.
Savkovic V; Dieckmann C; Milkova L; Simon JC
Exp Dermatol; 2012 Dec; 21(12):948-50. PubMed ID: 23171457
[TBL] [Abstract][Full Text] [Related]
8. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
[TBL] [Abstract][Full Text] [Related]
9. Effective culture conditions for the induction of pluripotent stem cells.
Okada M; Oka M; Yoneda Y
Biochim Biophys Acta; 2010 Sep; 1800(9):956-63. PubMed ID: 20417254
[TBL] [Abstract][Full Text] [Related]
10. Induction of retinal pigment epithelial cells from monkey iPS cells.
Okamoto S; Takahashi M
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8785-90. PubMed ID: 21896853
[TBL] [Abstract][Full Text] [Related]
11. Derivation of induced pluripotent stem cells from human peripheral circulating T cells.
Seki T; Yuasa S; Fukuda K
Curr Protoc Stem Cell Biol; 2011 Sep; Chapter 4():Unit4A.3. PubMed ID: 21913170
[TBL] [Abstract][Full Text] [Related]
12. Melanocytes derived from transgene-free human induced pluripotent stem cells.
Jones JC; Sabatini K; Liao X; Tran HT; Lynch CL; Morey RE; Glenn-Pratola V; Boscolo FS; Yang Q; Parast MM; Liu Y; Peterson SE; Laurent LC; Loring JF; Wang YC
J Invest Dermatol; 2013 Aug; 133(8):2104-8. PubMed ID: 23514962
[No Abstract] [Full Text] [Related]
13. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
López-González R; Velasco I
Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
[TBL] [Abstract][Full Text] [Related]
14. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
15. Optimization of culture conditions for the derivation and propagation of baboon (Papio anubis) induced pluripotent stem cells.
Navara CS; Chaudhari S; McCarrey JR
PLoS One; 2018; 13(3):e0193195. PubMed ID: 29494646
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
[TBL] [Abstract][Full Text] [Related]
17. iPS cell technology in regenerative medicine.
Lengner CJ
Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
[TBL] [Abstract][Full Text] [Related]
18. Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium.
Yamasaki S; Nabeshima K; Sotomaru Y; Taguchi Y; Mukasa H; Furue MK; Sato JD; Okamoto T
Int J Dev Biol; 2013; 57(9-10):715-24. PubMed ID: 24307297
[TBL] [Abstract][Full Text] [Related]
19. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
Javed MS; Yaqoob N; Iwamuro M; Kobayashi N; Fujiwara T
J Coll Physicians Surg Pak; 2014 Feb; 24(2):91-6. PubMed ID: 24491001
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells.
Noguchi M; Hosoda K; Nakane M; Mori E; Nakao K; Taura D; Yamamoto Y; Kusakabe T; Sone M; Sakurai H; Fujikura J; Ebihara K; Nakao K
Stem Cells Dev; 2013 Nov; 22(21):2895-905. PubMed ID: 23750558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
